Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. regarding potential breaches of fiduciary duties by the Company and certain officers [1] Group 1: Legal Investigation - The investigation is focused on whether ASP Isotopes and its executives breached their fiduciary duties to shareholders [1] - Shareholders who acquired ASP Isotopes securities prior to September 26, 2024, can seek corporate reforms and a court-approved incentive award at no cost [2][6] Group 2: Securities Fraud Allegations - A securities fraud class action complaint against ASP Isotopes was allowed to proceed after a partial denial of the defendants' motion to dismiss by the United States District Court for the Southern District of New York [3] - The complaint alleges that from September 2024, the Company made false statements regarding its uranium enrichment capabilities, claiming it had proprietary technology that was never tested [4] - These misrepresentations allegedly helped the Company raise approximately $18.6 million in gross proceeds while inflating its stock price [5]
Grabar Law Office Investigates Claims on Behalf of Investors of ASP Isotopes Inc. (ASPI) as Class Action Survives Motion to Dismiss